Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Moderator

John Anderson, MD

Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee

Disclosures

John Anderson, MD, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes; Alfa Sigma; AstraZeneca; Bayer; Boehringer Ingelheim; Eli Lilly; Gelesis; Novartis; Novo Nordisk; Sanofi
Speaker or member of speakers bureau for: AstraZeneca; Bayer; Eli Lilly; Novo Nordisk; Sanofi

Panelists

Eden Miller, DO

Director
Diabetes and Obesity Care
Bend, Oregon

Disclosures

Eden Miller, DO, has the following relevant financial relationships:
Consultant or advisor for: Abbott; Boehringer Ingelheim; Eli Lilly; Novo Nordisk
Speaker or member of speakers bureau for: Abbott; Boehringer Ingelheim; Eli Lilly; Novo Nordisk
Research funding from: Abbott; Pendulum

Eugene E. Wright, Jr. MD

Medical Director
Performance Improvement
Charlotte AHEC
Charlotte, North Carolina

Disclosures

Eugene E. Wright, Jr., MD, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care; Bayer; Boehringer Ingelheim/Lilly Alliance; Boehringer Ingelheim; GlaxoSmithKline; Lilly; Medtronic; Sanofi
Speaker or member of speakers bureau for: Abbott Diabetes Care; Bayer; Boehringer Ingelheim/Lilly Alliance; Boehringer Ingelheim; GlaxoSmithKline; Sanofi
Owns stock (publicly traded) in: Abbott

Editor

Anne G. Le, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Anne G. Le, PharmD, has no relevant financial relationships.

Compliance Reviewer

Susan L. Smith, MN, PhD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

CME / ABIM MOC

Continuous Glucose Monitoring for Type 2 Diabetes – Who, Why, and How?

Authors: John Anderson, MD; Eden Miller, DO; Eugene E. Wright, Jr. MD
CME / ABIM MOC Released: 10/14/2022
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 10/14/2023, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for primary care physicians, diabetologists, endocrinologists, nurse practitioners, physician assistants, and other clinicians interested in management of T2D.

The goal of this activity is that learners will be better able to use CGM in their patients with T2D who require insulin therapy.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Rationale for using CGM to manage patients with T2D
- Impact of lifestyle and pharmacotherapy for T2D on glycemic control
- Strategies for adjustments of the T2D management plan based on CGM data

Disclosures

Moderator

John Anderson, MD

Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee

Disclosures

John Anderson, MD, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes; Alfa Sigma; AstraZeneca; Bayer; Boehringer Ingelheim; Eli Lilly; Gelesis; Novartis; Novo Nordisk; Sanofi
Speaker or member of speakers bureau for: AstraZeneca; Bayer; Eli Lilly; Novo Nordisk; Sanofi

Panelists

Eden Miller, DO

Director
Diabetes and Obesity Care
Bend, Oregon

Disclosures

Eden Miller, DO, has the following relevant financial relationships:
Consultant or advisor for: Abbott; Boehringer Ingelheim; Eli Lilly; Novo Nordisk
Speaker or member of speakers bureau for: Abbott; Boehringer Ingelheim; Eli Lilly; Novo Nordisk
Research funding from: Abbott; Pendulum

Eugene E. Wright, Jr. MD

Medical Director
Performance Improvement
Charlotte AHEC
Charlotte, North Carolina

Disclosures

Eugene E. Wright, Jr., MD, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care; Bayer; Boehringer Ingelheim/Lilly Alliance; Boehringer Ingelheim; GlaxoSmithKline; Lilly; Medtronic; Sanofi
Speaker or member of speakers bureau for: Abbott Diabetes Care; Bayer; Boehringer Ingelheim/Lilly Alliance; Boehringer Ingelheim; GlaxoSmithKline; Sanofi
Owns stock (publicly traded) in: Abbott

Editor

Anne G. Le, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Anne G. Le, PharmD, has no relevant financial relationships.

Compliance Reviewer

Susan L. Smith, MN, PhD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Family Medicine

CME / ABIM MOC

Continuous Glucose Monitoring for Type 2 Diabetes – Who, Why, and How?

Authors: John Anderson, MD; Eden Miller, DO; Eugene E. Wright, Jr. MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC Released: 10/14/2022

Valid for credit through: 10/14/2023, 11:59 PM EST

processing....

CME / ABIM MOC Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Moderator

John Anderson, MD

Panelists

Eden Miller, DO

Eugene E. Wright, Jr. MD

Editor

Anne G. Le, PharmD

Compliance Reviewer

Susan L. Smith, MN, PhD

Peer Reviewer

CME / ABIM MOC

Continuous Glucose Monitoring for Type 2 Diabetes – Who, Why, and How?

Target Audience and Goal Statement

Disclosures

Moderator

John Anderson, MD

Panelists

Eden Miller, DO

Eugene E. Wright, Jr. MD

Editor

Anne G. Le, PharmD

Compliance Reviewer

Susan L. Smith, MN, PhD

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Continuous Glucose Monitoring for Type 2 Diabetes – Who, Why, and How?